Unknown

Dataset Information

Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.


ABSTRACT:

Background

Glycogen storage disease type Ia (GSD Ia) in dogs closely resembles human GSD Ia. Untreated patients with GSD Ia develop complications associated with glucose-6-phosphatase (G6Pase) deficiency. Survival of human patients on intensive nutritional management has improved; however, long-term complications persist including renal failure, nephrolithiasis, hepatocellular adenomas (HCA), and a high risk for hepatocellular carcinoma (HCC). Affected dogs fail to thrive with dietary therapy alone. Treatment with gene replacement therapy using adeno-associated viral vectors (AAV) expressing G6Pase has greatly prolonged life and prevented hypoglycemia in affected dogs. However, long-term complications have not been described to date.

Methods

Five GSD Ia-affected dogs treated

SUBMITTER: Brooks ED 

PROVIDER: S-EPMC6328337 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature